Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Glidewire GT-R

K-Number: K240859 · 2024-08-21

Decision Date2024-08-21
Product CodeDQX
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

Glidewire GT-R is a medical device manufactured by Terumo Corporation. It received FDA 510(k) clearance on 2024-08-21 under approval number K240859. The device is classified under product code DQX. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Glidewire GT-R?

Glidewire GT-R is a medical device that received FDA 510(k) clearance on 2024-08-21. It is manufactured by Terumo Corporation. The 510(k) number is K240859.

When was Glidewire GT-R approved by the FDA?

Glidewire GT-R received FDA 510(k) clearance on 2024-08-21, under approval number K240859.

What company makes Glidewire GT-R?

Glidewire GT-R is manufactured by Terumo Corporation.

What is the FDA product code for Glidewire GT-R?

The FDA product code for Glidewire GT-R is DQX.

Other Devices by Terumo Corporation

View all 9 devices →

Related Devices (Code: DQX)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.